1. Mimpara 5 mg zrnca v kapsulah za odpiranje

Mimpara 5 mg zrnca v kapsulah za odpiranje

Cinakalcet

General information

Drug nameMimpara 5 mg zrnca v kapsulah za odpiranje
Medicine nameCinakalcet
National drug code3000022
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug groupChemical Medicinal Product
OriginatorYes
Orphan drugNo

Marketing authorization

Procedure typePrenehanje veljavnosti dovoljenja za promet
No. and date of decision/certificateC(2026)9196, 18. 12. 2025
Authorization validity date18. 12. 2025
Marketing end date—
Application type—
Authorization/certificate holderAmgen Europe B.V.

Drug safety monitoring

Additional safety monitoringNo
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No

ATC codes

HSYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H05CALCIUM HOMEOSTASIS
H05BAnti-parathyroid agents
H05BXOther anti-parathyroid agents
H05BX01cinacalcet

Route of administration

Route of administration name
Peroralna uporaba

Settlement data for compulsory health insurance billing

Substitute medicine

Preparation—
Valid from – to—

Clinical use data

Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo

Shortage actions

Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo

Drug status

Permanent cessation of marketing of the medicinal product.

Last drug update date:9. 7. 2026
TEST APPLICATION